Monday, February 16, 2026 2/16/2026

Targeting collagen as an interventional approach to improve bone material properties

Award Number: R01AR072609
ORGANIZATION: NATIONAL INSTITUTE OF ARTHRITIS & MUSCULOSKELETAL & SKIN DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/05/2018
PERIOD OF PERFORMANCE END DATE: 05/31/2024

Group Awards By:

View Award Description

Targeting collagen as an interventional approach to improve bone material properties - PROJECT SUMMARY Mechanical loading and pharmaceutical interventions both improve bone mechanical properties, but there is a critical gap in our understanding of the role that collagen plays in mediating these effects. This gap in knowledge by which collagen processing, organization, mineralization, and hydration change with combined load and drug treatment is a critical impediment to the development of combination therapies that increase fracture resistance by targeting tissue moieties other than mineral. Our long-term goal is to develop ways to alter physical properties of bone tissue to increase fracture resistance. The overall objective in this application is to elucidate how mechanical loading and a RAL-analog (RALA) modify newly forming and pre-existing bone to decrease fragility. The central hypothesis is that in addition to changes in mass and mineral, collagen-modifying effects exist for both loading and RALA, the combination of which interactively improve mechanical integrity beyond the effects of either monotherapy. The premise of this hypothesis stems from preliminary data generated in the applicants' laboratories. The rationale for the proposed work is that successfully making bone stronger and more resistant to fracture by combining RALA's hydrating effects with mechanical regulation of bone mass and perilacunar matrix activity could provide alternative ways for the orthopaedic community to approach the treatment of bone diseases. Guided by preliminary data, this hypothesis will be tested using three specific aims: 1) to define influences of loading on osteocyte perilacunar matrix activity and osteoblast matrix deposition; 2) to determine how RAL/RALA modify collagen quality and matrix hydration; and 3) to determine interactive effects of loading and RALA. Under the first aim, techniques already in place will be used to investigate in vitro and in vivo loading effects in healthy cells and animals, as well as in models of disrupted collagen synthesis. In vitro loading will be induced by substrate stretching for osteoblasts or pulsatile fluid flow for osteocytes. Gene expression of enzymes and chaperones will be quantified, as well as molecules associated with resorption. Matrix production, organization, composition and mechanical integrity will be assessed. For in vivo loading experiments, similar techniques will be used to assess collagen synthesis, post-translational modifications, and crosslinking along with nanoscale and whole bone tests of mechanical integrity, fatigue resistance and fracture toughness. In Aim 2, outcome measures from Aim 1 will be used to investigate the effects of RAL/RALA as a function of disease state. In Aim 3, interactive effects of combined loading and drug-based treatment will be assessed. The approach is innovative because of its focus on collagen, in addition to mass and architecture. It also focuses on osteoblast- produced collagen on surfaces and changes induced by osteocytes throughout the bone. This work is significant because it will demonstrate that interactions through combination therapies can improve skeletal mechanical phenotypes, not by correcting the disease cause, but by impacting collagen synthesis, assembly, mineralization, and tissue hydration. Such knowledge will provide new ways to approach treatment of fragility-related diseases.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2022	TRUSTEES OF INDIANA UNIVERSITY	980 INDIANA AVE RM 2232	INDIANAPOLIS	IN	46202	MARION	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	5	9/26/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = $343,035 )
2022	2022	TRUSTEES OF INDIANA UNIVERSITY	980 INDIANA AVE RM 2232	INDIANAPOLIS	IN	46202	MARION	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	5	6/8/2022	NON-COMPETING CONTINUATION	$343,035
														Subtotal = $343,035

Issue Date FY: 2021 ( Subtotal = $336,105 )
2021	2021	TRUSTEES OF INDIANA UNIVERSITY	980 INDIANA AVE RM 2232	INDIANAPOLIS	IN	46202	MARION	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	4	5/19/2021	NON-COMPETING CONTINUATION	$336,105
														Subtotal = $336,105

Issue Date FY: 2020 ( Subtotal = $346,500 )
2020	2020	TRUSTEES OF INDIANA UNIVERSITY	980 INDIANA AVE RM 2232	INDIANAPOLIS	IN	46202	MARION	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	3	5/5/2020	NON-COMPETING CONTINUATION	$346,500
														Subtotal = $346,500

Issue Date FY: 2019 ( Subtotal = $346,500 )
2019	2019	TRUSTEES OF INDIANA UNIVERSITY	980 INDIANA AVE RM 2232	INDIANAPOLIS	IN	46202	MARION	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	2	5/7/2019	NON-COMPETING CONTINUATION	$346,500
														Subtotal = $346,500

Issue Date FY: 2018 ( Subtotal = $346,500 )
2018	2018	TRUSTEES OF INDIANA UNIVERSITY	980 INDIANA AVE RM 2232	INDIANAPOLIS	IN	46202	MARION	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	1	7/4/2018	NEW	$346,500
														Subtotal = $346,500

Grand Total All Awards = $1,718,640

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Targeting collagen as an interventional approach to improve bone material properties

Award Number: R01AR072609

ORGANIZATION: NATIONAL INSTITUTE OF ARTHRITIS & MUSCULOSKELETAL & SKIN DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/05/2018

PERIOD OF PERFORMANCE END DATE: 05/31/2024

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer